Phage therapy shows promise for treating bacterial infections, including those resistant to antibiotics, but its development faces scientific and regulatory hurdles. This Perspective outlines the regulatory landscape in TATFAR member states and their collaborative effort to advance phage therapy.
- Kyung Moon
- Carmen Coxon
- Marco Cavaleri
